Which of the following is a KEY DISADVANTAGE of case-control studies compared to cohort studies in epidemiological research?

Explanation

## Key Disadvantage of Case-Control Studies **Key Point:** The **most fundamental** limitation of case-control studies is that they **cannot directly calculate incidence rates**. Because the investigator artificially fixes the ratio of cases to controls, the sample does not reflect the true population distribution of disease, making incidence calculation impossible. ### Why Option C is the MOST Fundamental Disadvantage In a case-control study: - You **select cases** (people with disease) and **controls** (people without disease) at a fixed ratio chosen by the investigator (e.g., 1:1, 1:2, 1:4) - You then look **backward** to ascertain exposure history - The **proportion of cases in the sample is artificially determined**, not representative of the true population prevalence or incidence - Therefore, you **cannot calculate true incidence** in exposed and unexposed groups — the denominator (population at risk over time) is simply not available This is why case-control studies use the **Odds Ratio (OR)** rather than Relative Risk (RR). The OR approximates RR only when the disease is **rare** in the population (< 10%) — the "rare disease assumption" (Park's Textbook of Preventive and Social Medicine). ### Why Option A is Incorrect as the KEY Disadvantage Option A states case-control studies "cannot establish temporal relationship between exposure and disease." This is **partially misleading and not the most fundamental limitation**: - Case-control studies *can* establish temporality if exposure data are collected carefully (e.g., using medical records, biological specimens stored before disease onset) - The inability to establish temporality is a **practical challenge**, not an inherent design impossibility - In contrast, the inability to calculate incidence is an **absolute, inherent design constraint** — no amount of careful data collection can overcome it - Cohort studies are superior for temporality, but this is a relative, not absolute, disadvantage of case-control design ### Why Options B and D are Incorrect - **Option B** ("Requires large sample size and long follow-up") is actually a disadvantage of **cohort studies**, not case-control studies. Case-control studies are typically smaller, faster, and cheaper — this is one of their *advantages*. - **Option D** ("Prone to selection bias but not recall bias") is factually **wrong**. Case-control studies are classically prone to **both** selection bias AND recall bias (differential recall of past exposures by cases vs. controls). Recall bias is one of the most cited weaknesses of case-control design. ### Comparison Table | Aspect | Cohort Study | Case-Control Study | |--------|--------------|--------------------| | **Starts with** | Exposure status | Disease status | | **Direction** | Forward (prospective) | Backward (retrospective) | | **Incidence calculable?** | ✓ Yes | ✗ No (absolute limitation) | | **Measure of association** | Relative Risk (RR) | Odds Ratio (OR) | | **Sample size** | Usually larger | Usually smaller | | **Cost & time** | High | Low | | **Recall bias** | Less prone | More prone | **High-Yield (Park / Mahajan):** The inability to calculate incidence is the single most fundamental design limitation of case-control studies, distinguishing them structurally from cohort studies. This is why they are called "retrospective" and why they rely on OR as a proxy for RR. **Clinical Pearl:** When a question asks for the *key* or *most fundamental* disadvantage of case-control studies, always choose **inability to calculate incidence rates** over temporality issues, because the latter can sometimes be addressed by study design modifications, while the former cannot.